Skip to main content
SpringerLink
Log in

Evaluation and Treatment of Superficial Esophageal Cancer

  • DeMeester Festschrift
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Introduction

Adenocarcinoma of the esophagus is the fastest increasing cancer in the USA, and an increasing number of patients are identified with early-stage disease. The evaluation and treatment of these superficial cancers differs from local and regionally advanced lesions.

Methods

This paper is a review of the current methods to diagnose, stage, and treat superficial esophageal adenocarcinoma.

Results

Intramucosal adenocarcinoma can be effectively treated with endoscopic resection techniques and with less morbid surgical options including a vagal-sparing esophagectomy. However, submucosal lesions are associated with a significant risk for lymph node metastases and are best treated with esophagectomy and lymphadenectomy.

Discussion

There has been a major shift in the treatment for Barrett’s high-grade dysplasia and superficial esophageal adenocarcinoma in the past 10 years. New therapies minimize the morbidity and mortality of traditional forms of esophagectomy and in some cases allow esophageal preservation. Individualization of therapy will allow maximization of successful outcome and quality of life with minimization of complications and recurrence of Barrett’s or cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97(2):142–146.

    Article  PubMed  Google Scholar 

  2. Brown LM, Devesa SS, Chow W-H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100(16):1184–1187.

    Article  PubMed  Google Scholar 

  3. Crane LMA, Schaapveld M, Visser O, et al. Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival. Eur J Cancer 2007;43(9):1445–1451.

    Article  PubMed  Google Scholar 

  4. Oh DS, Hagen JA, Chandrasoma PT, et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg 2006;203(2):152–161.

    Article  PubMed  Google Scholar 

  5. Rice TW, Blackstone EH, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001;122(6):1077–1090.

    Article  CAS  PubMed  Google Scholar 

  6. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242(4):566–573. discussion 573–5.

    PubMed  Google Scholar 

  7. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999;230(3):433–440.

    Article  CAS  PubMed  Google Scholar 

  8. May A, Gunter E, Roth F, et al. Accuracy of staging in early esophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004;53:634–640.

    Article  CAS  PubMed  Google Scholar 

  9. Maish MS, DeMeester SR. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004;78:1777–1782.

    Article  PubMed  Google Scholar 

  10. Tada M, Inoue H, Yabata E, et al. Colonic mucosal resection using a transparent cap-fitted endoscope.[see comment]. Gastrointest Endosc 1996;44(1):63–65.

    Article  CAS  PubMed  Google Scholar 

  11. Prasad GA, Buttar NS, Wongkeesong LM, et al. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol 2007;102(11):2380–2386.

    Article  PubMed  Google Scholar 

  12. Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008;57(9):1200–1206.

    Article  CAS  PubMed  Google Scholar 

  13. Schembre DB, Huang JL, Lin OS, et al. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.[see comment]. Gastrointest Endosc 2008;67(4):595–601.

    Article  PubMed  Google Scholar 

  14. Liu LMDP, Hofstetter WLMD, Rashid AMDP, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 2005;29:1079–1085.

    PubMed  Google Scholar 

  15. Peyre C, DeMeester SR, Rizzetto C, et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett's with high-grade dysplasia. Ann Surg 2007;246:665–674.

    Article  PubMed  Google Scholar 

  16. Rice TW, Zuccaro G Jr, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998;65(3):787–792.

    Article  CAS  PubMed  Google Scholar 

  17. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy [see comments]. J Thorac Cardiovasc Surg 1999;117(1):16–23. discussion 23–5.

    Article  CAS  PubMed  Google Scholar 

  18. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).[see comment]. Gastrointest Endosc 2007;65(1):3–10.

    Article  PubMed  Google Scholar 

  19. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118(4):670–677.

    Article  CAS  PubMed  Google Scholar 

  20. Buttar N, Nijhawan P, Krishnadath K, et al. Combined endoscopic mucosal resection (EMR) and photodynamic therapy (PDT) for esophageal neoplasia within Barrett's esophagus. Gastroenterology 2000;118:A405.

    Google Scholar 

  21. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients.[see comment]. Gastrointest Endosc 2007;65(2):185–195.

    Article  PubMed  Google Scholar 

  22. Lang L. Radiofrequency ablation is effective treatment for dysplasia in Barrett's esophagus. Gastroenterology 2008;135(1):6.

    Google Scholar 

  23. Hernandez JC, Reicher S, Chung D, et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 2008;40(5):388–392.

    Article  CAS  PubMed  Google Scholar 

  24. Manner H, May A, Pech O, et al. Early Barrett's carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008;103(10):2589–2597.

    Article  PubMed  Google Scholar 

  25. Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 2004;8(7):890–897. discussion 897–8.

    Article  PubMed  Google Scholar 

  26. Katz PO. Review article: the role of non-acid reflux in gastro-oesophageal reflux disease. Aliment Pharmacol & Ther 2000;14(12):1539–1551.

    Article  CAS  Google Scholar 

  27. Lord RV, Wickramasinghe K, Johansson JJ, et al. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. Surgery 2004;136(3):633–640.

    Article  PubMed  Google Scholar 

  28. Oberg S, Johansson J, Wenner J, Walther B. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 2002;235:338–345.

    Article  PubMed  Google Scholar 

  29. Krishnadath KK, Wang KK, Taniguchi K, et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000;119(3):624–630.

    Article  CAS  PubMed  Google Scholar 

  30. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.[see comment]. Gastrointest Endosc 2003;58(2):183–188.

    Article  PubMed  Google Scholar 

  31. Prasad GA, Wang KK, Halling KC, et al. Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer 2008;113(3):470–476.

    Article  PubMed  Google Scholar 

  32. Overholt BF, Wang KK, Burdick JS, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.[see comment]. Gastrointest Endosc 2007;66(3):460–468.

    Article  PubMed  Google Scholar 

  33. Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 2007;246(3):363–372. discussion 372–4.

    Article  PubMed  Google Scholar 

  34. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Esophageal stripping with preservation of the vagus nerve. Int Surg 1982;67(2):125–128.

    CAS  PubMed  Google Scholar 

  35. Banki F, Mason RJ, DeMeester SR, et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002;236(3):324–335. discussion 335–6.

    Article  PubMed  Google Scholar 

  36. Peyre CG, DeMeester SR, Rizzetto C, et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia. Ann Surg 2007;246(4):665–671. discussion 671–4.

    Article  PubMed  Google Scholar 

  37. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405(6785):458–462.

    Article  CAS  PubMed  Google Scholar 

  38. van Westerloo DJ, Giebelen IAJ, Florquin S, et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005;191(12):2138–2148.

    Article  PubMed  Google Scholar 

  39. Luyer MD, Greve JWM, Hadfoune Mh, et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005;202(8):1023–1029.

    Article  CAS  PubMed  Google Scholar 

  40. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997;114(5):824–829.

    Article  CAS  PubMed  Google Scholar 

  41. Headrick JR, Nichols FC 3rd, Miller DL, et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy.[see comment]. Ann Thorac Surg 2002;73(6):1697–1702. discussion 1702–3.

    Article  PubMed  Google Scholar 

  42. Williams VA, Watson TJ, Herbella FA, et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 2007;11(12):1589–1597.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiothoracic Surgery, The University of Southern California, Los Angeles, CA, 90033, USA

    Steven R. DeMeester

Authors
  1. Steven R. DeMeester
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven R. DeMeester.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeMeester, S.R. Evaluation and Treatment of Superficial Esophageal Cancer. J Gastrointest Surg 14 (Suppl 1), 94–100 (2010). https://doi.org/10.1007/s11605-009-1025-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-009-1025-1

Keywords

Search

Navigation